<Suppliers Price>

CEP-8983

Names

[ CAS No. ]:
374071-46-2

[ Name ]:
CEP-8983

[Synonym ]:
7-methoxy-1,2,3,11-tetrahydro-5,11-diaza-benzo[a]trindene-4,6-dione
1H-Cyclopenta(a)pyrrolo(3,4-c)carbazole-1,3(2H)-dione,4,5,6,7-tetrahydro-11-methoxy

Biological Activity

[Description]:

CEP-8983 is a PARP-1 and PARP-2 inhibitor (IC50: 20 and 6 nM). CEP-8983 is an effective chemosensitizing agent, and can sensitize chemotherapy-resistant cell lines and subcutaneous xenografts to Temozolomide (HY-17364) and Camptothecin (HY-16560)[1].

[Related Catalog]:

Research Areas >> Cancer
Signaling Pathways >> Epigenetics >> PARP
Signaling Pathways >> Cell Cycle/DNA Damage >> PARP

[Target]

20 and 6 nM (PARP-1/2)[1].


[References]

[1]. Miknyoczki S, et al. The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity. Mol Cancer Ther. 2007 Aug;6(8):2290-302.  

Chemical & Physical Properties

[ Molecular Formula ]:
C18H14N2O3

[ Molecular Weight ]:
306.31500

[ Exact Mass ]:
306.10000

[ PSA ]:
74.68000

[ LogP ]:
2.71240

Synthetic Route

Precursor & DownStream


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.